There were 1,826 press releases posted in the last 24 hours and 442,417 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Nanobiotix partners with Weill Cornell Medicine on pre-clinical studies to evaluate the impact of NBTXR3 on cGAS-STING pathway in mammary cancers

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image